{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:43:15Z","timestamp":1770478995799,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.lfs.2008.03.023","type":"journal-article","created":{"date-parts":[[2008,4,11]],"date-time":"2008-04-11T19:06:28Z","timestamp":1207940788000},"page":"1154-1161","source":"Crossref","is-referenced-by-count":35,"title":["AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice"],"prefix":"10.1016","volume":"82","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.lfs.2008.03.023_bib1","first-page":"2369","article-title":"Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes","volume":"63","author":"Armeanu","year":"2003","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.lfs.2008.03.023_bib2","first-page":"826","article-title":"Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene","volume":"59","author":"Horikawa","year":"1999","journal-title":"Cancer Research"},{"issue":"10","key":"10.1016\/j.lfs.2008.03.023_bib3","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1158\/1078-0432.CCR-03-0512","article-title":"Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter","volume":"10","author":"Jacob","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1016\/j.lfs.2008.03.023_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.cgt.7700773","article-title":"Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter","volume":"12","author":"Jacob","year":"2005","journal-title":"Cancer Gene Therapy"},{"issue":"5","key":"10.1016\/j.lfs.2008.03.023_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/75045","article-title":"Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand","volume":"6","author":"Jo","year":"2000","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.lfs.2008.03.023_bib6","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1158\/0008-5472.CAN-04-2657","article-title":"Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication","volume":"65","author":"Kamizono","year":"2005","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/j.lfs.2008.03.023_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1016-8478(23)13739-3","article-title":"TRAIL, a might apoptosis inducer","volume":"15","author":"Kim","year":"2003","journal-title":"Molecules and Cells"},{"issue":"10","key":"10.1016\/j.lfs.2008.03.023_bib8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1089\/10430340050057477","article-title":"A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter","volume":"11","author":"Koga","year":"2000","journal-title":"Human Gene Therapy"},{"issue":"3","key":"10.1016\/j.lfs.2008.03.023_bib9","first-page":"553","article-title":"Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes","volume":"60","author":"Leverkus","year":"2000","journal-title":"Cancer Research"},{"issue":"52","key":"10.1016\/j.lfs.2008.03.023_bib10","doi-asserted-by":"crossref","first-page":"8020","DOI":"10.1038\/sj.onc.1205926","article-title":"Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells","volume":"21","author":"Lin","year":"2002","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.lfs.2008.03.023_bib11","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/hep.20918","article-title":"Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice","volume":"42","author":"Ma","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lfs.2008.03.023_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ijc.20982","article-title":"Recombinant adeno-associated virus-mediated TRAIL gene therapy suppresses liver metastatic tumors","volume":"116","author":"Ma","year":"2005","journal-title":"International Journal of Cancer"},{"issue":"7","key":"10.1016\/j.lfs.2008.03.023_bib13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.gt.3301421","article-title":"The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters","volume":"8","author":"Majumdar","year":"2001","journal-title":"Gene Therapy"},{"issue":"3","key":"10.1016\/j.lfs.2008.03.023_bib14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V98.3.795","article-title":"TRAIL\/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications","volume":"98","author":"Mitsiades","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.lfs.2008.03.023_bib15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/sj.gt.3302154","article-title":"AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression","volume":"11","author":"Mohr","year":"2004","journal-title":"Gene Therapy"},{"issue":"4","key":"10.1016\/j.lfs.2008.03.023_bib16","first-page":"847","article-title":"Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo","volume":"60","author":"Nagane","year":"2005","journal-title":"Cancer Research"},{"issue":"20","key":"10.1016\/j.lfs.2008.03.023_bib17","first-page":"5800","article-title":"Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice","volume":"62","author":"Naka","year":"2002","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/j.lfs.2008.03.023_bib18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.onc.1205151","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells","volume":"21","author":"Nesterov","year":"2002","journal-title":"Oncogene"},{"issue":"9232","key":"10.1016\/j.lfs.2008.03.023_bib19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","article-title":"Human brain-cell death induced by tumour necrosis factor-related apoptosis-inducing ligand","volume":"356","author":"Nitsch","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lfs.2008.03.023_bib20","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/0008-5472.CAN-03-1786","article-title":"Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding encoding angiostatin and endostatin over vectors encoding a single factor","volume":"64","author":"Ponnazhagan","year":"2004","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.lfs.2008.03.023_bib21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4049\/jimmunol.170.2.1027","article-title":"Acceleration of human neutrophil apoptosis by TRAIL","volume":"170","author":"Renshaw","year":"2003","journal-title":"Journal of Immunology"},{"issue":"5","key":"10.1016\/j.lfs.2008.03.023_bib22","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1158\/0008-5472.CAN-04-2749","article-title":"Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice","volume":"65","author":"Shi","year":"2005","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.lfs.2008.03.023_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1271\/bbb.69.56","article-title":"Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer","volume":"69","author":"Song","year":"2005","journal-title":"Bioscience Biotechnology Biochemistry"},{"issue":"16","key":"10.1016\/j.lfs.2008.03.023_bib24","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1158\/1078-0432.CCR-05-0502","article-title":"Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models","volume":"11","author":"Streck","year":"2005","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.lfs.2008.03.023_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.gt.3302352","article-title":"Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice","volume":"12","author":"Subramanian","year":"2005","journal-title":"Gene Therapy"},{"issue":"4","key":"10.1016\/j.lfs.2008.03.023_bib26","first-page":"3273","article-title":"Regulatory regions of growth-related genes can activate an exogenous gene of the \u03b1-Fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells","volume":"23","author":"Tomizawa","year":"2003","journal-title":"Anticancer Research"},{"issue":"4","key":"10.1016\/j.lfs.2008.03.023_bib27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/jns.2006.104.4.583","article-title":"The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma","volume":"104","author":"Van Houdt","year":"2006","journal-title":"Journal of Neurosurgery"},{"issue":"2","key":"10.1016\/j.lfs.2008.03.023_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.lfs.2008.03.023_bib29","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/sj.cgt.7700403","article-title":"Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma","volume":"8","author":"Wesseling","year":"2001","journal-title":"Cancer Gene Therapy"},{"issue":"3","key":"10.1016\/j.lfs.2008.03.023_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/mthe.2001.0275","article-title":"Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers","volume":"3","author":"Yamamoto","year":"2001","journal-title":"Molecular Therapy"},{"issue":"3","key":"10.1016\/j.lfs.2008.03.023_bib31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/jhep.2000.16266","article-title":"Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines","volume":"32","author":"Yamanaka","year":"2000","journal-title":"Hepatology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432050800129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432050800129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T21:53:42Z","timestamp":1708811622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432050800129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":31,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S002432050800129X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2008.03.023","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}